ArticleJournal of enzyme inhibition and medicinal chemistry2020

The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75.

Da-Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.